SCHEMBL165923

SCHEMBL165923

CN(C)CCCN1CCNCC1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 2/20 0.50
SIGMAR1 Q99720 4/20 0.49
ALOX15 P16050 1/20 0.44
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PIM1 P11309 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM5 P08912 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
HSD17B10 Q99714 1/20 0.37
GNAI3 P08754 3/20 0.37
GNAO1 P09471 3/20 0.37
GNAI1 P63096 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL19410287 0.98 CXCR4 (0.48) CXCR4SIGMAR1ALOX15POLBSMN1; SMN2
Hydrochloric Acid SCHEMBL21812908 0.98 CXCR4 (0.48) CXCR4SIGMAR1ALOX15POLBSMN1; SMN2
SCHEMBL2236609 0.94 CXCR4 (0.52) CXCR4SIGMAR1ALOX15POLBSMN1; SMN2
SCHEMBL12501275 0.92 CXCR4 (0.63) CXCR4SIGMAR1ALOX15POLBSMN1; SMN2
Carbamic Acid SCHEMBL8817104 0.88 SIGMAR1 (0.41) CXCR4SIGMAR1ALOX15SMN1; SMN2ALDH1A1
SCHEMBL20333695 0.87 CXCR4 (0.50) CXCR4SIGMAR1POLBSMN1; SMN2ALDH1A1
SCHEMBL2912801 0.86 ALDH1A1 (0.45) CXCR4SIGMAR1POLBSMN1; SMN2PIM1
SCHEMBL19604 0.86 ALDH1A1 (0.45) CXCR4SIGMAR1POLBSMN1; SMN2PIM1
Hydrochloric Acid SCHEMBL6151027 0.84 ALDH1A1 (0.44) CXCR4SIGMAR1POLBSMN1; SMN2PIM1
Piperazine SCHEMBL27980522 0.84 CXCR4 (0.47) CXCR4SIGMAR1POLBSMN1; SMN2PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 738 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116102700-B Softening agent and preparation method thereof 江苏奥斯佳材料科技股份有限公司 2024-12-10 CN claimed
CN-116285775-A High-performance chloroprene rubber adhesive and preparation method thereof 上谷新材料(苏州)有限公司 2023-06-23 CN claimed
CN-116102700-A Softening agent and preparation method thereof 江苏奥斯佳材料科技股份有限公司 2023-05-12 CN claimed
CN-112961303-B Softening agent for soft polyurethane foam and application thereof 江苏奥斯佳材料科技股份有限公司 2023-01-03 CN claimed
EP-3241856-B1 POLYURETHANE CATALYST AND APPLICATION THEREOF JIANGSU OSIC PERFORMANCE MAT CO LTD (CN) 2021-08-18 EP claimed
CN-112961303-A Softening agent for soft polyurethane foam and application thereof 江苏奥斯佳材料科技股份有限公司 2021-06-15 CN claimed
CN-112940212-A Polyurethane catalyst, automotive polyurethane material and preparation method thereof 江苏奥斯佳材料科技股份有限公司 2021-06-11 CN claimed
US-10889681-B2 Polyurethane catalyst and application thereof JIANGSU OSIC PERFORMANCE MATERIALS CO. LTD. (CN) 2021-01-12 US claimed
US-20180273671-A1 POLYURETHANE CATALYST AND APPLICATION THEREOF JIANGSU OSIC PERFORMANCE MATERIALS CO. LTD. (CN) 2018-09-27 US claimed
CN-104558469-B A kind of application of catalysts for polyurethanes in flexible polyurethane foam is synthesized 江苏奥斯佳材料科技有限公司 2018-02-23 CN claimed
EP-2193150-A2 SYNTHESIS OF A LIQUID POLYMER AND A FUNCTIONALIZED POLYMER Bridgestone Corporation (JP) 2010-06-09 EP claimed
WO-2009032154-A2 SYNTHESIS OF A LIQUID POLYMER AND A FUNCTIONALIZED POLYMER BRIDGESTONE CORPORATION (JP) 2009-03-12 WO claimed
US-20090062451-A1 SYNTHESIS OF A LIQUID POLYMER AND A FUNCTIONALIZED POLYMER BRIDGESTONE CORPORATION (JP) 2009-03-05 US claimed
JP-2008521903-A 2008-06-26 JP claimed
CN-101193867-A N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole libraries OSI PHARM INC (US) 2008-06-04 CN claimed
EP-1831206-A2 N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY OSI Pharmaceuticals, Inc. (US) 2007-09-12 EP claimed
WO-2007006585-A2 SYNTHESIS OF A POROUS AND/OR STRATIFIED STRUCTURE MANGANESE OXIDE ELSPER RUEDIGER (DE) 2007-01-18 WO claimed
WO-2006060381-A2 N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY OSI PHARMACEUTICALS, INC. (US) 2006-06-08 WO claimed
US-20060116402-A1 N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library OSI PHARMACEUTICALS, INC. 2006-06-01 US claimed
US-4161475-A OIL ADDITIVES, DISPERSANTS THE LUBRIZOL CORPORATION (US) 1979-07-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062451-A1 SYNTHESIS OF A LIQUID POLYMER AND A FUNCTIONALIZED POLYMER FGB, FIP1L1, PUF60 CXCR4 3430/4885SIGMAR1 4371/4885ALOX15 1145/4885
US-20060116402-A1 N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library KIT, CHUK, TNNI3K CXCR4 1901/4885SIGMAR1 3147/4885ALOX15 3763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.